Systemic Immune-Inflammatory Index, Tumor-Infiltrating Lymphocytes, and Clinical Outcomes in Esophageal Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy.
Jun YangJifang ZhengJianjian QiuMengyan ZhangLingyun LiuZhiping WangQunhao ZhengYanyan LiuMingqiu ChenJiancheng LiPublished in: Journal of immunology research (2023)
SII and TIL as independent predictors of clinical outcomes in EC receiving CCRT. Furthermore, the predictive power of the two combinations is much higher than a single variable.